Thalidomide-induced remission of lichen planopilaris [2]

Journal of the American Academy of Dermatology

Volumn 47, Issue 6, 2002, Pages 967-968

  Boyd, Alan S ^a   King Jr , Lloyd E ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b Nashville Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; CASE REPORT; CONSTIPATION; DROWSINESS; DRUG EFFECT; DRUG INDUCED DISEASE; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HEADACHE; HUMAN; INFLAMMATORY INFILTRATE; LETTER; LICHEN PLANUS; MOOD DISORDER; POSTMENOPAUSE; PRIORITY JOURNAL; REMISSION; TERATOGENICITY; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LICHEN PLANUS; MALE; MIDDLE AGED; POSTMENOPAUSE; SCALP DERMATOSES; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0036893987     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Stirling DI. Thalidomide and its impact in dermatology. Semin Cutan Med Surg 1998;17:231-42.
2. Naafs B, Faber WR. Thalidomide therapy: An open trial. Int J Dermatol 1985;24:131-4.
3. Perez AR, Weiss E, Piquero Martin J, Rondon Lugo AJ. Liquen plano generalizado con lesion erosiva del pene, teratado con thalidomida; reporte de un caso y revision de la literatura. Med Cutan Ibero Lat Am 1987;15:321-6.
4. Dereure O, Basset-Seguin N, Guilhou JJ. Erosive lichen planus: Dramatic response to thalidomide. Arch Dermatol 1996;132:1392-3.
5. Txeng S, Pak G, Washenik K, et al. Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996;35:969-79.
6. Ochonisky S, Verroust J, Bastuji-Garin S, et al. Thalidomide neuropathy incidence and clincoelectrophysiologic findings in 42 patients. Arch Dermatol 1994;130:66-9.
7. Gad SM, Shannon EJ, Krotoski WA, et al. Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males. Lepr Rev 1985;56:35-9.
8. McHugh SM, Rifkin IR, Deighton J, et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995;99:160-7.
9. Sampaio EP, Sarno EN, Galilly R, et al. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991;173:699-703.
10. Boyd AS. Update on the diagnosis of lichenoid dermatitis. Adv Dermatol 1996;11:287-315.